| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 673773 | 73671 | OLMESARTAN SANDOZ 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN SANDOZ 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73671/73671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73671/73671_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2017-01-11 | View Edit Delete | ||||||||||||
| 673774 | 73672 | TELMISARTAN NORMON 20 mg COMPRIMIDOS EFG | TELMISARTAN NORMON 20 mg COMPRIMIDOS EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73672/73672_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73672/73672_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2014-01-10 | View Edit Delete | ||||||||||||
| 673775 | 73673 | OLMESARTAN SANDOZ 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN SANDOZ 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73673/73673_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73673/73673_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2017-01-11 | View Edit Delete | ||||||||||||
| 673776 | 73674 | TELMISARTAN NORMON 80 mg COMPRIMIDOS EFG | TELMISARTAN NORMON 80 mg COMPRIMIDOS EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73674/73674_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73674/73674_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2014-01-10 | View Edit Delete | ||||||||||||
| 673778 | 73676 | HIDROCLOROTIAZIDA STADA 50 mg COMPRIMIDOS EFG | HIDROCLOROTIAZIDA STADA 50 mg COMPRIMIDOS EFG, 20 comprimidos | 50 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73676/73676_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73676/73676_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-11-04 | View Edit Delete | ||||||||||||
| 673779 | 73677 | OLANZAPINA FLAS QUALIGEN 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS QUALIGEN 5 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73677/73677_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73677/73677_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 673780 | 61406 | AMARYL 2 mg COMPRIMIDOS | AMARYL 2 mg COMPRIMIDOS , 120 comprimidos | 2 mg | 5 | 120 | 10 | 120 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61406/61406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61406/61406_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40842 | SANOFI AVENTIS S.A. | 1997-05-01 | 1 | 1 | 1 | 1997-05-01 | 1997-05-01 | 1 | 2011-06-09 | View Edit Delete | ||||||||||||
| 673781 | 73678 | OLANZAPINA FLAS QUALIGEN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS QUALIGEN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73678/73678_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73678/73678_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 673782 | 73678 | OLANZAPINA FLAS QUALIGEN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS QUALIGEN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73678/73678_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73678/73678_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 673785 | 73680 | OLANZAPINA FLAS KERN PHARMA 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS KERN PHARMA 5 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73680/73680_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73680/73680_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-03-22 | 1 | 1 | 1 | 2011-03-22 | 2011-03-22 | 1 | 2011-05-17 | View Edit Delete | ||||||||||||
| 673787 | 73682 | OLANZAPINA FLAS KERN PHARMA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS KERN PHARMA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73682/73682_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73682/73682_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-03-22 | 1 | 1 | 1 | 2011-03-22 | 2011-03-22 | 1 | 2011-05-17 | View Edit Delete | ||||||||||||
| 673788 | 73682 | OLANZAPINA FLAS KERN PHARMA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS KERN PHARMA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73682/73682_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73682/73682_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-03-22 | 1 | 1 | 1 | 2011-03-22 | 2011-03-22 | 1 | 2011-05-17 | View Edit Delete | ||||||||||||
| 673793 | 73686 | OLANZAPINA FLAS CINFA 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS CINFA 5 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73686/73686_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73686/73686_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2011-03-22 | 1 | 1 | 1 | 2011-03-22 | 2011-03-22 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 673805 | 73689 | OLANZAPINA FLAS CINFA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS CINFA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73689/73689_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73689/73689_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2011-03-22 | 1 | 1 | 1 | 2011-03-22 | 2011-03-22 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 673807 | 73689 | OLANZAPINA FLAS CINFA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS CINFA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73689/73689_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73689/73689_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2011-03-22 | 1 | 1 | 1 | 2011-03-22 | 2011-03-22 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 673814 | 61404 | ENANDOL 12,5 mg/g GEL | ENANDOL 12,5 mg/g GEL, 1 tubo de 60 g | 12,5 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61404/61404_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61404/61404_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27816 | MENARINI CONSUMER HEALTHCARE S.A.U. | 1999-11-01 | 1 | 1 | 1 | 1999-11-01 | 1999-11-01 | 1 | 2025-07-23 | View Edit Delete | ||||||||||||
| 673815 | 73690 | CANDESARTAN/HIDROCLOROTIAZIDA SANDOZ 16 mg/12,5 mg COMPRIMIDOS EFG | CANDESARTAN/HIDROCLOROTIAZIDA SANDOZ 16 mg/12,5 mg COMPRIMIDOS EFG , 28 comprimidos | 16 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73690/73690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73690/73690_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-03-30 | 1 | 1 | 1 | 2011-03-30 | 2011-03-30 | 1 | 2012-05-02 | View Edit Delete | ||||||||||||
| 673822 | 61403 | ENANGEL 12,5 mg/g GEL | ENANGEL 12,5 mg/g GEL , 1 tubo de 60 g | 12,5 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61403/61403_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61403/61403_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1803 | LABORATORIOS MENARINI S.A. | 1999-11-01 | 1 | 1 | 1 | 1999-11-01 | 1999-11-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 673838 | 73691 | RABEPRAZOL VIATRIS 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | RABEPRAZOL VIATRIS 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73691/73691_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73691/73691_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | VIATRIS PHARMACEUTICALS S.L. | 2011-03-22 | 1 | 1 | 1 | 2011-03-22 | 2011-03-22 | 1 | 2011-10-31 | View Edit Delete | ||||||||||||
| 673839 | 73692 | OLANZAPINA FLAS TARBIS 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS TARBIS 5 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73692/73692_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73692/73692_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-03-22 | 1 | 1 | 1 | 2011-03-22 | 2011-03-22 | 1 | 2012-11-21 | View Edit Delete |
Page 265 of 1035, showing 20 records out of 20697 total, starting on record 5281, ending on 5300